Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Capital Expenditures (2018 - 2024)

Dna X's Capital Expenditures history spans 7 years, with the latest figure at $8000.0 for Q4 2024.

  • Quarterly results put Capital Expenditures at $8000.0 for Q4 2024, down 33.33% from a year ago — trailing twelve months through Dec 2024 was $214000.0 (up 1326.67% YoY), and the annual figure for FY2024 was $214000.0, up 494.44%.
  • Capital Expenditures for Q4 2024 was $8000.0 at Dna X, down from $137000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $184000.0 in Q1 2020 to a low of -$75000.0 in Q4 2020.
  • The 5-year median for Capital Expenditures is $9500.0 (2020), against an average of $27785.7.
  • The sharpest move saw Capital Expenditures tumbled 98.49% in 2020, then skyrocketed 13600.0% in 2024.
  • Year by year, Capital Expenditures stood at -$75000.0 in 2020, then soared by 134.67% to $26000.0 in 2021, then tumbled by 92.31% to $2000.0 in 2022, then skyrocketed by 500.0% to $12000.0 in 2023, then plummeted by 33.33% to $8000.0 in 2024.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $8000.0, $137000.0, and $39000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.